Monarch Partners Asset Management LLC Castle Biosciences Inc Transaction History

Monarch Partners Asset Management LLC

$328 Million
Q4 2022

A detailed history of Monarch Partners Asset Management LLC transactions in Castle Biosciences Inc stock. As of the latest transaction made, Monarch Partners Asset Management LLC holds 170,195 shares of CSTL stock, worth $4.68 Million. This represents 1.22% of its overall portfolio holdings.

Number of Shares

170,195

Previous 188,631 9.77%

Holding current value

$4.68 Million

Previous $4.92 Million 18.56%

% of portfolio

1.22%

Previous 1.48%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 02, 2023	SELL	$18.08 - $30.0 $333,322 - $553,080	-18,436 Reduced 9.77%	170,195 $4.01 Million
Q3 2022 Oct 31, 2022	BUY	$22.51 - $34.32 $1.25 Million - $1.91 Million	55,589 Added 41.78%	188,631 $4.92 Million
Q2 2022 Jul 20, 2022	SELL	$16.0 - $45.99 $375,360 - $1.08 Million	-23,460 Reduced 14.99%	133,042 $2.92 Million
Q1 2022 May 06, 2022	BUY	$33.17 - $46.98 $1.39 Million - $1.97 Million	41,838 Added 36.49%	156,502 $7.02 Million
Q4 2021 Feb 03, 2022	SELL	$39.06 - $67.58 $1.87 Million - $3.23 Million	-47,804 Reduced 29.42%	114,664 $4.92 Million
Q3 2021 Nov 04, 2021	BUY	$60.13 - $77.6 $515,975 - $665,885	8,581 Added 5.58%	162,468 $10.8 Million
Q2 2021 Jul 30, 2021	BUY	$50.07 - $76.78 $7.02 Million - $10.8 Million	140,227 Added 1026.55%	153,887 $11.3 Million
Q1 2021 May 11, 2021	SELL	$58.92 - $97.33 $3.85 Million - $6.35 Million	-65,272 Reduced 82.69%	13,660 $935,000
Q4 2020 Feb 04, 2021	SELL	$43.6 - $73.05 $781,399 - $1.31 Million	-17,922 Reduced 18.5%	78,932 $5.3 Million
Q3 2020 Nov 05, 2020	BUY	$38.47 - $52.03 $2.85 Million - $3.85 Million	74,039 Added 324.52%	96,854 $4.98 Million
Q2 2020 Jul 31, 2020	BUY	$27.28 - $43.01 $202,281 - $318,919	7,415 Added 48.15%	22,815 $860,000
Q1 2020 May 04, 2020	BUY	$23.08 - $35.53 $120,708 - $185,821	5,230 Added 51.43%	15,400 $459,000
Q4 2019 Feb 05, 2020	SELL	$15.74 - $35.04 $101,050 - $224,956	-6,420 Reduced 38.7%	10,170 $350,000
Q3 2019 Nov 04, 2019	BUY	$18.09 - $27.92 $300,113 - $463,192	16,590 New	16,590 $300,000

Others Institutions Holding CSTL

# of Institutions

201

Shares Held

24.5M

Call Options Held

303K

Put Options Held

30.3K

View Full List

About CASTLE BIOSCIENCES INC

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $723M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

More about CSTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Monarch Partners Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Monarch Partners Asset Management LLC with notifications on news.

Account

Monarch Partners Asset Management LLC Castle Biosciences Inc Transaction History